Previous 10 | Next 10 |
Gainers: DBV Technologies (DBVT) +21%. Rubius Therapeutics (RUBY) +20%. Annovis Bio (ANVS) +17%. LumiraDx (LMDX) +16%. CTI BioPharma (CTIC) +15%. Losers: Rigel Pharmaceuticals (RIGL) -48%. Cosmos (COSM) -13%. Accelerate Diagnostics (AXDX) ...
At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging (NNOX), ADMA Biologics (ADMA),&...
FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“ Celularity ”), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appointment of Diane Parks to its Board o...
CTI BioPharma to Present at Upcoming June Conferences PR Newswire SEATTLE , June 2, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at two upcoming investor conferences in New Yor...
CTI BioPharma Corp. (NASDAQ:CTIC) traded at a new 52-week high today of $6.21. This new high was reached on below average trading volume as 200,000 shares traded hands, while the average 30-day volume is approximately 3.6 million shares. CTI BioPharma Corp. (NASDAQ:CTIC) defies analysts ...
CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting PR Newswire SEATTLE , May 26, 2022 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced a poster presentation from t...
GeoVax Labs (GOVX) +20%. Inovio Pharmaceuticals (INO) +19%. SIGA Technologies SIGA +15% Monkeypox plays indicate further upside as global toll climbs. O2Micro International (OIIM) +13%. GoldMining (GLDG) +12%. Emergent BioSolutions EBS +12% Monkeypox plays indicate further...
Shares of CTI BioPharma (NASDAQ: CTIC) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased with the initial sales figures for Vonjo, its first approved drug, and pushed the stock price 20.8% higher as of 11:22 a.m. ET. O...
CTI BioPharma Corp. (CTIC) Q1 2022 Earnings Conference Call May 12, 2022, 04:30 PM ET Company Participants Adam Craig - CEO and President of CTI BioPharma James Fong - SVP and Chief Commercial Officer David Kirske - EVP, CFO and Secretary Conference Call Participants Robert Hazlett - BTIG Ben...
CTI BioPharma press release (NASDAQ:CTIC): Q1 GAAP EPS of -$0.37 beats by $0.04. Revenue of $2.3M beats by $0.76M. As of March 31, 2022, our cash and cash equivalents totaled $96.9 million. For further details see: CTI BioPharma GAAP EPS of -$0.37 beats by $0.04, revenue of $2.3M beats ...
News, Short Squeeze, Breakout and More Instantly...
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders PR Newswire SEATTLE , May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization ...
Shares of CTI BioPharma Corp. (NASDAQ: CTIC) traded at a new 52-week high today and are currently trading at $8.99. So far today, approximately 1.79M shares have been exchanged, as compared to an average 30-day volume of 10.16M shares. CTI BioPharma Corp., a biopharmaceutical company, focuses...
NEW YORK, NY / ACCESSWIRE / May 16, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Franchise Group, Inc. (NASDAQ: FRG)'s ...